Interest of Auriculotherapy in the Treatment of Xerostomia (NCT04222478) | Clinical Trial Compass
RecruitingNot Applicable
Interest of Auriculotherapy in the Treatment of Xerostomia
France68 participantsStarted 2019-12-04
Plain-language summary
The aim of the study is to show that auriculotherapy is effective in the treatment of xerostomia
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients over 18 years old;
* Complain about xerostomia after cervical irradiation in the context of ENT cancer;
* End of radiotherapy\> 3 months
* Covered by a national healthcare insurance
* Consent form signed.
Non inclusion Criteria:
* Pregnant or breastfeeding women;
* Local counterindication to auriculotherapy;
* With anticoagulant treatment;
* History or existing of hemophilia;
* Valvular prosthesis;
* Ear's pavilion infection;
* Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months;
* Having started in the 48 hours preceding the first auriculotherapy session, any new management of xerostomia and likely to interfere with the study (specific medication and/or complementary therapeutic management);
* Difficulty to comply with the treatment, questionnaires or study protocol;
* Being deprived of liberty or under guardianship.
What they're measuring
1
Number of patients with improvement of salivation after 3 month of treatment (Real Auriculotherapy group compared to Sham Auriculotherapy group)